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Clara Cieza-Borrella1, Koveela Govindasami1, Mark N. Brook1, Christopher A. Haiman2, David V. Conti2,
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British Journal of Cancer (2019) 120:867; https://doi.org/10.1038/s41416-019-0419-4
Correction to: British Journal of Cancer (2018) 119:96–104; https://
doi.org/10.1038/s41416-018-0141-7; http://www.bjcancer.com; pub-
lished online 19 June 2018
This article was originally published under the standard License
to Publish, but has now been made available under a CC BY 4.0
license. The PDF and HTML versions of the paper have been
modified accordingly.
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